SCHEMBL28688459

SCHEMBL28688459

CC(C)C1CN(Cc2ccccc2)Cc2ccc(Cl)nc21

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.41
TACR1 P25103 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
ACHE P22303 1/20 0.39
SIGMAR1 Q99720 3/20 0.39
SLC6A12 P48065 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PNMT P11086 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912868 0.83 ACHE (0.42) MC4RMEN1KMT2AESR1ESR2
SCHEMBL29883093 0.83 ACHE (0.42) MC4RMEN1KMT2AESR1ESR2
SCHEMBL28693977 0.81 ESR1 (0.40) MC4RMEN1KMT2AESR1ESR2
SCHEMBL28689000 0.77 ESR1 (0.39) MC4RMEN1KMT2AKDM4EESR1
SCHEMBL28671430 0.74 PRMT5 (0.46) ACHE
SCHEMBL29883371 0.74 PRMT5 (0.46) ACHE
SCHEMBL2109285 0.73 CYP1A2 (0.39) MC4RMEN1KMT2AKDM4EESR1
SCHEMBL29883119 0.71 KMT2A (0.63) MEN1KMT2AKDM4ESIGMAR1NPC1
SCHEMBL1038680 0.71 KMT2A (0.63) MEN1KMT2AKDM4ESIGMAR1NPC1
SCHEMBL2110977 0.71 CYP1A2 (0.45) MC4RMEN1KMT2ASIGMAR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113880866-B Aza-tetrahydronaphthyridine compound, preparation method thereof, pharmaceutical composition and application thereof 上海维申医药有限公司 2022-09-27 CN disclosed
CN-113880866-A Aza-tetrahydronaphthyridine compound, preparation method thereof, pharmaceutical composition and application thereof 上海维申医药有限公司 2022-01-04 CN disclosed